Carbamazepine-induced dystonia in an adolescent

Dystonia is sustained muscle contraction, which may be primary or secondary to other causes. Drugs comprise one of the most important causes for the secondary dystonia, the usual mechanism being a dopaminergic blockade. There are very few reports describing dystonia resulting from carbamazepine (CBZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Shwetank, Gill, Manpreet, Bhasin, Chhavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900012/
https://www.ncbi.nlm.nih.gov/pubmed/27298509
http://dx.doi.org/10.4103/0253-7613.182879
_version_ 1782436568902926336
author Bansal, Shwetank
Gill, Manpreet
Bhasin, Chhavi
author_facet Bansal, Shwetank
Gill, Manpreet
Bhasin, Chhavi
author_sort Bansal, Shwetank
collection PubMed
description Dystonia is sustained muscle contraction, which may be primary or secondary to other causes. Drugs comprise one of the most important causes for the secondary dystonia, the usual mechanism being a dopaminergic blockade. There are very few reports describing dystonia resulting from carbamazepine (CBZ) administration. In this case report, a 16-year-old male with mental retardation and seizure disorder developed dystonia at therapeutic blood levels of CBZ.
format Online
Article
Text
id pubmed-4900012
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49000122016-06-13 Carbamazepine-induced dystonia in an adolescent Bansal, Shwetank Gill, Manpreet Bhasin, Chhavi Indian J Pharmacol Drug Watch Dystonia is sustained muscle contraction, which may be primary or secondary to other causes. Drugs comprise one of the most important causes for the secondary dystonia, the usual mechanism being a dopaminergic blockade. There are very few reports describing dystonia resulting from carbamazepine (CBZ) administration. In this case report, a 16-year-old male with mental retardation and seizure disorder developed dystonia at therapeutic blood levels of CBZ. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4900012/ /pubmed/27298509 http://dx.doi.org/10.4103/0253-7613.182879 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Drug Watch
Bansal, Shwetank
Gill, Manpreet
Bhasin, Chhavi
Carbamazepine-induced dystonia in an adolescent
title Carbamazepine-induced dystonia in an adolescent
title_full Carbamazepine-induced dystonia in an adolescent
title_fullStr Carbamazepine-induced dystonia in an adolescent
title_full_unstemmed Carbamazepine-induced dystonia in an adolescent
title_short Carbamazepine-induced dystonia in an adolescent
title_sort carbamazepine-induced dystonia in an adolescent
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900012/
https://www.ncbi.nlm.nih.gov/pubmed/27298509
http://dx.doi.org/10.4103/0253-7613.182879
work_keys_str_mv AT bansalshwetank carbamazepineinduceddystoniainanadolescent
AT gillmanpreet carbamazepineinduceddystoniainanadolescent
AT bhasinchhavi carbamazepineinduceddystoniainanadolescent

Ejemplares similares